Credit: Pixabay/CC0 Public Domain A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer Institute and 23andMe Research Institute....
HONG KONG, Sept. 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that AK158D1, its investigational next-generation bispecific antibody-drug conjugate (ADC) targeting EGFR and TROP2, has secured Phase I clinical trial clearance from the Center for Drug...
HONG KONG, Sept. 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that AK158D1, its investigational next-generation bispecific antibody-drug conjugate (ADC) targeting EGFR and TROP2, has secured Phase I clinical trial clearance from the Center for Drug...
This is a paid press release. Contact the press release distributor directly with any inquiries. Akeso's EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate PR Newswire Wed, September 16,...
Zipalertinib Added to Chemotherapy Improves Progression-Free Survival in First-Line EGFR Exon 20 Mutation–Positive NSCLC The addition of zipalertinib to platinum/pemetrexed chemotherapy led to a significant improvement in progression-free survival in patients with advanced non–small cell lung cancer (NSCLC) harboring an...
Ahmet Dirican: WCLC26 Highlights New Options for EGFR Exon20ins NSCLC Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared on X:. “At WCLC26, the Phase III REZILIENT3 trial evaluated zipalertinib + chemotherapy as 1L treatment for advanced...
BioTech JNJ J&J's RYBREVANT Plus Chemotherapy Sets New Benchmark In EGFR Exon 20 Insertion NSCLC Survival September 14, 2026 - 04:09 am EDT Written by RTTNews.com for RTTNews linkedin facebook x email reddit (RTTNews) - Johnson & Johnson (JNJ) announced...
BioTech CGEM Cullinan's Zipalertinib Plus Chemotherapy Extends PFS By 6 Months In EGFR Ex20+ Lung Cancer September 13, 2026 - 10:19 pm EDT Written by RTTNews.com for RTTNews linkedin facebook x email reddit (RTTNews) - Cullinan Therapeutics, Inc (CGEM), Taiho...
